The core of the job

Most MSLs spend their week across four repeating activities, and every job description is a variation on these.

• Scientific exchange with key opinion leaders (KOLs) — peer-level discussion of data, mechanism, and clinical practice.
• Insight generation — capturing what clinicians say about unmet need, competitors, and barriers, then feeding it back to medical strategy.
• Internal and external education — training field teams, supporting advisory boards, presenting at congresses.
• Trial and investigator support — site identification, investigator-initiated study discussions, and protocol context.

What it is not

MSLs do not carry sales targets, do not promote off-label, and do not sit in an office. Roughly 50–70% of the role is field travel within a defined territory, with the remainder in preparation, reporting, and cross-functional meetings.

The degree

The overwhelming majority of MSL postings ask for a PhD, PharmD, MD, or an equivalent doctoral-level clinical degree. A minority — often in devices, diagnostics, or smaller biotechs — accept an MSc, RN, or PA with strong clinical experience.

• PhD: strongest for early-pipeline and highly scientific assets (oncology, rare disease, immunology).
• PharmD: strongest where dosing, formulary, and payer conversations dominate.
• MD / clinical practitioner: strongest where practice-pattern credibility with peers is the differentiator.
• MSc / RN / PA: viable with deep specialty experience, but expect a narrower set of open roles.

Therapeutic-area depth

Companies hire for a specific asset in a specific area. Your research, clinical rotations, or publications should point clearly at one area — oncology, immunology, neurology, cardiometabolic, rare disease — rather than reading as generalist.

The skills that decide the shortlist

Every candidate at interview has the degree. What separates offers from rejections is the softer competency set.

• Explaining complex data at three registers: KOL, community clinician, and payer.
• Territory and stakeholder planning — thinking in tiers, cadence, and coverage rather than ad-hoc meetings.
• Compliance instinct — knowing exactly how to handle an unsolicited off-label question.
• Cross-functional influence with commercial, market access, and clinical development.
• Comfort with heavy travel, autonomy, and self-directed prioritisation.

Months 0–3: positioning

Choose one therapeutic area and commit to it. Rewrite your CV in industry language — outcomes, stakeholders, and impact rather than methods and techniques. Rebuild your LinkedIn headline around the target role, not your current one.

Months 3–6: evidence and network

Build visible proof: a congress poster, a review article, a journal club you run, teaching or training you deliver. In parallel, hold 15–20 informational conversations with MSLs and MSL managers in your area — most first roles come through referral, not job boards.

Months 6–12: applying properly

Expect to tailor every application to the specific asset and pipeline. A generic CV is the single most common reason strong scientists never reach a first screen. Anticipate three to five rounds per company, including a scientific presentation.

Months 12–18: the fallback routes

If direct MSL entry stalls, the adjacent entry points hire on a similar profile and convert well: Medical Information, Medical Writing, Clinical Research Associate, or an MSL role at a CRO or a small biotech. Two years in one of these makes the MSL move substantially easier.

Morning

Early literature scan and prep for the day's meetings — the specific KOL's publications, their trial involvement, and any data that has moved since you last met. Travel to the first site.

Midday

One to three KOL meetings: a 30–45 minute scientific exchange each, often squeezed between clinics. You listen more than you present. Every interaction produces an insight worth capturing the same day.

Afternoon

Insight write-up in the CRM, follow-up on a Medical Information request, and a cross-functional call with medical strategy or market access. Possibly a site visit around an investigator-initiated study.

The rhythm across a month

Two to three field days a week, one office or home day for planning and reporting, and one day absorbed by internal meetings, training, or congress preparation. Add four to eight congresses and advisory boards a year.

From academia (PhD / postdoc)

Strength: scientific depth and comfort with primary literature. Gap: commercial context and stakeholder skill. Close it by translating your CV from methods to impact, taking on teaching or committee roles, and learning the pipeline and competitive landscape of your target companies.

From clinical practice (MD / PharmD / RN)

Strength: peer credibility and practice-pattern insight. Gap: industry process — compliance frameworks, cross-functional working, and CRM discipline. Close it by joining advisory boards as a participant, speaking at industry-sponsored education, and learning the medical-commercial boundary.

From another pharma function

Strength: you already know the operating model. Gap: field credibility and therapeutic-area depth. Close it by getting formally attached to a medical project, shadowing MSL field days, and building a publication or congress presence in the target area.

From CRO or clinical research

Strength: trial fluency and investigator relationships. Gap: strategic framing — moving from execution to insight and influence. Close it by leading investigator communications, owning site-facing scientific content, and evidencing how your input changed a decision.